Open AccessCharacterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data
Author(s) -
Kathleen Mortimer,
Dorothee B. Bartels,
N Hartmann,
Jorge Capapey,
Jing Yang,
Robert Gately,
Cheryl Enger
Publication year - 2020
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000504630
Subject(s) - medicine , idiopathic pulmonary fibrosis , cohort , incidence (geometry) , interstitial lung disease , disease , pulmonary hypertension , gastroenterology , lung , physics , optics
Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease (ILD). Characterizing health outcomes of IPF patients is challenging due to disease rarity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom